Navigation Links
Scripps Research announces research & license agreement with Janssen Pharmaceuticals
Date:5/7/2013

LA JOLLA, CA May 7, 2013 The Scripps Research Institute (TSRI) today announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus. Under the agreement Janssen will receive certain license rights to the results of the research. Janssen Pharmaceuticals will collaborate in the research on influenza through its Crucell Vaccine Institute.

"We're delighted to partner with Janssen in this work that could have a significant impact on human health," said Michael A. Marletta, president and CEO of TSRI. "The new agreement leverages the institute's significant strengths in structural biology to move forward new therapies and vaccines."

Scott Forrest, TSRI's vice president for business development, added, "This deal is the latest example of our corporate partnership strategy, in which we seek focused collaborations to match companies' specific areas of interest with areas of expertise among multiple TSRI labs."

The new agreement builds on research on the influenza virus conducted jointly by TSRI and Janssen's Crucell Vaccine Institute. Previous collaborations have resulted in several high-impact publications, most recently in August 2012 in the journal Science.

Seasonal flu typically causes more than 200,000 hospitalizations and 36,000 deaths every year in the United States, according to estimates by the U.S. Centers for Disease Control. Pandemics pose a greater dangerthe Spanish Flu of 1918-1919 may have killed 50 million people worldwide.

The new strategic collaboration with Janssen follows TSRI's announcement of a five-year agreement with Bristol-Myers Squibb last June; that agreement covered the development of chemistry methodologies and related work.

Forrest notes that promising future areas for corporate partnerships at TSRI include Oncology, Neurodegeneration and Immunology.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome
2. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
3. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
4. Scripps Research Institute scientists develop antidote for cocaine overdose
5. Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
6. Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
7. Scripps Florida scientist awarded $1.5 million to design therapeutics with new RNA approach
8. Scripps Florida scientists identify neurotranmitters that lead to forgetting
9. Plastic trash altering ocean habitats, Scripps study shows
10. Scripps Florida scientists awarded $8.4 million grant to develop new anti-smoking treatments
11. Esther B. OKeeffe Foundation gives $2 million to the Scripps Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2018)... Pa. (PRWEB) , ... November 08, 2018 , ... ... with advanced touch screen control. Heating blocks, also known as dry bath incubators ... variety of tubes and containers. , For the new heating blocks, Boekel ...
(Date:11/7/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD ... experience in clinical trial management, including managing operations and trials focused on oncology ... joined the firm as an Expert Consultant. , Prior to joining NDA ...
(Date:11/6/2018)... FRANCISCO (PRWEB) , ... November 06, 2018 , ... uBiome, ... of Biochemistry and Biophysics at the University of California, San Francisco (UCSF) and Co-President ... as a scientific adviser to uBiome since 2013, and we are honored that he ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... ... 2Blades’ Transcription Activator Like (TAL) effector code technology for applications in advancing research ... the technology in plants. Since its discovery in 2009, the efficacy of TAL effector-based ...
(Date:10/31/2018)... ... October 30, 2018 , ... Pippa Rose is a young Labrador retriever. Like ... old, Pippa suffered a partial tear to the cruciate ligament in her right knee. ... go on walks. Kinsley reported that it broke her heart to see Pippa lie ...
(Date:10/24/2018)... ... 22, 2018 , ... Erchonia, the leading low-level laser technology ... an episode of CBS’s hit show “The Doctors” which aired on ... , discusses and demonstrates the Lunula Laser’s unique capacity to zap away toe ...
(Date:10/18/2018)... (PRWEB) , ... October 18, 2018 , ... ... genomic sequencing laboratory in the San Francisco Bay Area has received accreditation from ... operations, and patient safety. , Predicine received CAP accreditation for its Shanghai facility ...
Breaking Biology Technology: